Status:
UNKNOWN
Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients
Lead Sponsor:
University of the Philippines
Collaborating Sponsors:
Philippine Coconut Authority
Philippine Council for Health Research & Development
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)
Detailed Description
This study will be a randomized controlled trial among hospitalized COVID-19 patients, aged 18 years old and above, admitted at the Philippine General hospital. Patients will be grouped into the follo...
Eligibility Criteria
Inclusion
- symptomatic and asymptomatic COVID-19 hospitalized patients
- has laboratory-confirmed illness during the time of recruitment
- able to take food and medicines enterally
Exclusion
- uncontrolled or newly diagnosed diabetes mellitus
- with chronic heart disease
- having elevated lipid profile at baseline (admission)
Key Trial Info
Start Date :
October 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 9 2022
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04849637
Start Date
October 22 2020
End Date
April 9 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philippine General Hospital
Manila, National Capital Region, Philippines, 1000